Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Frank S. David"'
Autor:
Rena M. Conti, Frank S. David
Publikováno v:
F1000Research, Vol 9 (2020)
In the debate over prescription drug pricing, some pharmaceutical industry critics claim that U.S. taxpayers pay twice for costly therapies, because publicly supported research is a major contributor to drug discovery and American taxpayers are inade
Externí odkaz:
https://doaj.org/article/2aeb9b72d5f340bd871b2230320a8c9c
Autor:
Frank S. David, Richa Dixit
Publikováno v:
F1000Research, Vol 7 (2018)
In recent years, several drug companies have exploited U.S. regulatory policies to acquire exclusive rights to cheap therapies and substantially raise their prices, and Federal agencies and state governments are exploring various ways to prevent or p
Externí odkaz:
https://doaj.org/article/97ad2e9223414199bfe7370e09a128f0
Publikováno v:
PLoS ONE, Vol 15, Iss 11, p e0241425 (2020)
In response to stagnant Federal grant funding levels and to catalyze early stage or high-risk research not currently supported by the NIH, many academic medical centers (AMCs) provide supplemental intramural funding to faculty investigators. However,
Externí odkaz:
https://doaj.org/article/79211b678ec543bb9d486f1420c5d18a
Autor:
Greg Williams, Andor W. J. M. Glaudemans, Marcie Clarkin, Alan W. Harris, de Elisabeth G. E. Vries, Frank S. David, Michel Koole, K. Banks, Janine Doorduin, G Hattersley
Publikováno v:
Cancer Research. 76:P6-13
Estrogen and the estrogen receptor (ER) are known to be prominent drivers of breast tumourigenesis and breast cancer progression. Hormonal agents that target the ER such as selective estrogen receptor modulators (SERMs) and selective estrogen recepto
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1b75931b3692cc98616be01a2b143054
https://doi.org/10.1158/1538-7445.sabcs15-p6-13-02
https://doi.org/10.1158/1538-7445.sabcs15-p6-13-02
Autor:
Frank S. David, Rena M. Conti
Publikováno v:
F1000Research
In the debate over prescription drug pricing, some pharmaceutical industry critics claim that U.S. taxpayers pay twice for costly therapies, because publicly supported research is a major contributor to drug discovery and American taxpayers are inade
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::39c3406686833bf82d851db53c13f231
https://doi.org/10.12688/f1000research.24934.1
https://doi.org/10.12688/f1000research.24934.1
Publikováno v:
JAMA Network Open. 3:e200172
This cross-sectional study uses combined statistical areas to explore whether the availability of clinical trial seats in nonrural regions varies with population, racial and socioeconomic compositions, research activity, or the amount of health care
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d0ed4c0482846a8f214a228e5bde40a
https://doi.org/10.1001/jamanetworkopen.2020.0172
https://doi.org/10.1001/jamanetworkopen.2020.0172
Autor:
Dan E. Azagury, Kevin E. Behrns, Katherine S. Blevins, Mark Boden, David E. Chadwick, Venita Chandra, Mark S. Cohen, Elizabeth Cole, Frank S. David, Lyn Denend, Ryan D. Egeland, James C. Eisenach, Thomas J. Filarski, C. Corbin Frye, Johnathan Goldstein, Andy Hayden, Theodore W. Heise, Thomas Hobday, James Hood, Seth Klapman, Thomas M. Krummel, Priya Kumthekar, Eric Leuthardt, Thomas R. Mackie, Josh Makower, Dennis Matthews, Rudy A. Mazzocchi, Kyle Miller, Barry S. Myers, Deepa Narayanan, Jenell Paul-Robinson, Zachary Rapp, Charles Robert Hallford, Lee L. Sanström, Michael G. Sarr, Jay Schrankler, Thomas P. Stossel, Mamta Swaroop, William D. Voorhees, James K. Wall, Tom Walsh, Michael Weingarten, Elisabeth K. Wynne, Carla L. Zema
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e319dde538951ea78d6eeea3821fb1e6
https://doi.org/10.1016/b978-0-12-814926-3.09988-5
https://doi.org/10.1016/b978-0-12-814926-3.09988-5
We summarize insights from hospital finance professionals on how they evaluate new operating room-based surgical devices. The importance of this report is that it provides surgeon-innovators with actionable opportunities to develop surgical devices t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9a44815539ea0aa0fe407cb47cec8cd8
https://doi.org/10.1016/b978-0-12-814926-3.00017-6
https://doi.org/10.1016/b978-0-12-814926-3.00017-6
Autor:
Richa Dixit, Frank S. David
Publikováno v:
F1000Research
In recent years, several drug companies have exploited U.S. regulatory policies to acquire exclusive rights to cheap therapies and substantially raise their prices, and Federal agencies and state governments are exploring various ways to prevent or p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da816e97eab8a503afb83b7ab424cef3
http://europepmc.org/articles/PMC5865197
http://europepmc.org/articles/PMC5865197
Autor:
Richa, Dixit, Frank S, David
Publikováno v:
Nature reviews. Drug discovery. 16(6)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::40d362cafe3d40f88139448e562dbfca
https://pubmed.ncbi.nlm.nih.gov/28496145
https://pubmed.ncbi.nlm.nih.gov/28496145